NAMSAÂ Launches Market Intelligence Report on Global Medical Device Clinical Outsourcing Trends

NAMSA® Launches Market Intelligence Report on Global Medical Device Clinical Outsourcing Trends

07:05 EDT 30 Oct 2018 | Businesswire
NAMSA

NAMSA®, the world’s only Medical Research Organization (MRO) that accelerates medical device development through integrated laboratory testing, clinical research and regulatory consulting services is pleased to announce the release of its 2018 Medical Device Landscape Report: Trends and Challenges in Clinical Research Outsourcing.

This report, conducted on behalf of NAMSA by the Avoca Group, is comprised of over 200 responses from global medical device Sponsors with responsibility for clinical research outsourcing. Contained within is newly-discovered market data surrounding medical device clinical research—an area that has grown 63% since 2012 (ClinicalTrials.gov)—and an in-depth look at outsourcing behaviors and the most significant drivers, barriers and opportunities for medical device development.

“We are extremely pleased to provide new information to the medical device marketplace surrounding the unique challenges and opportunities for clinical research and outsourcing. In comparison to the pharmaceutical industry, little data existed previously regarding medical device outsourcing obstacles and how they might be addressed to achieve stronger CRO/Sponsor partnerships,” commented Christopher Rupp, NAMSA’s Director of Global Marketing & Sales Operations. “With significant medical device growth expected globally—$619B by 2022 (GlobalData)—it is imperative that we find strategies to work together to efficiently bring novel technologies to market and to quickly deliver them to patients who need them most,” Rupp concluded.

NAMSA’s 2018 Medical Device Landscape Report Executive Summary findings demonstrate that medical device Sponsors are experiencing the following trends and challenges related to clinical research and outsourcing:

NAMSA invites you to download our full report to gain access to this previously unavailable medical device clinical research outsourcing data. We anticipate that this information will serve as a beneficial tool as we work together to advance global patient healthcare through the delivery of life-improving medical technologies.

Contact Us

Are NAMSA’s clinical research and regulatory consulting services a good fit for your needs? Contact us at +1-866-666-9455 (+1-419-666-9455 outside of the U.S.) or by visiting www.namsa.com/contact-us/.

About NAMSA

NAMSA is a Medical Research Organization (MRO), accelerating medical device product development through integrated laboratory, clinical and consulting services. Driven by our regulatory expertise, NAMSA’s MRO® Approach plays an important role in translational research, applying a unique combination of disciplines—consulting, regulatory, preclinical, toxicology, microbiology, chemistry, clinical and quality—to move clients’ products through the development process, and continue to provide support through commercialization to post-market requirements anywhere in the world.

NAMSA
Leah Davidson, MA, MBA, 612-615-6985
Marketing Communications Manager
ldavidson@namsa.com

More From BioPortfolio on "NAMSA® Launches Market Intelligence Report on Global Medical Device Clinical Outsourcing Trends"